Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis
Tóm tắt
Từ khóa
Tài liệu tham khảo
X Zheng, 2014, Survival outcome after stereotactic body radiation therapy and surgery for stage I non-small cell lung cancer: a meta-analysis, International journal of radiation oncology, biology, physics, 90, 603, 10.1016/j.ijrobp.2014.05.055
P Goldstraw, 2007, The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer, 2, 706, 10.1097/JTO.0b013e31812f3c1a
T Naruke, 2001, Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience, The Annals of thoracic surgery, 71, 1759, 10.1016/S0003-4975(00)02609-6
SH Moon, 2013, Prognostic significance of volume-based PET parameters in cancer patients, Korean journal of radiology: official journal of the Korean Radiological Society, 14, 1, 10.3348/kjr.2013.14.1.1
A Zhu, 2011, Metabolic positron emission tomography imaging in cancer detection and therapy response, Seminars in oncology, 38, 55, 10.1053/j.seminoncol.2010.11.012
V Paidpally, 2012, FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma, Imaging in medicine, 4, 633, 10.2217/iim.12.60
J Davison, 2013, PET-based primary tumor volumetric parameters and survival of patients with non-small cell lung carcinoma, AJR American journal of roentgenology, 200, 635, 10.2214/AJR.12.9138
F Na, 2014, Primary tumor standardized uptake value measured on F18-Fluorodeoxyglucose positron emission tomography is of prediction value for survival and local control in non-small-cell lung cancer receiving radiotherapy: meta-analysis, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer, 9, 834, 10.1097/JTO.0000000000000185
VS Nair, 2009, Positron emission tomography 18F-fluorodeoxyglucose uptake and prognosis in patients with surgically treated, stage I non-small cell lung cancer: a systematic review, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer, 4, 1473, 10.1097/JTO.0b013e3181bccbc6
M Paesmans, 2010, Primary tumor standardized uptake value measured on fluorodeoxyglucose positron emission tomography is of prognostic value for survival in non-small cell lung cancer: update of a systematic review and meta-analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer Staging Project, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer, 5, 612, 10.1097/JTO.0b013e3181d0a4f5
HJ Im, 2015, Prognostic value of volumetric parameters of (18)F-FDG PET in non-small-cell lung cancer: a meta-analysis, European journal of nuclear medicine and molecular imaging, 42, 241, 10.1007/s00259-014-2903-7
D Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, PLoS medicine, 6, e1000097, 10.1371/journal.pmed.1000097
K Pak, 2014, Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis in Head and Neck Cancer: A Systematic Review and Meta-Analysis, Journal of nuclear medicine: official publication, Society of Nuclear Medicine, 55, 884, 10.2967/jnumed.113.133801
T Berghmans, 2008, Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer, 3, 6, 10.1097/JTO.0b013e31815e6d6b
L Pan, 2009, Prognostic significance of SUV on PET/CT in patients with esophageal cancer: a systematic review and meta-analysis, European journal of gastroenterology & hepatology, 21, 1008, 10.1097/MEG.0b013e328323d6fa
JF Tierney, 2007, Practical methods for incorporating summary time-to-event data into meta-analysis, Trials, 8, 16, 10.1186/1745-6215-8-16
J Dinnes, 2005, A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy, Health Technol Assess, 9, 1, 10.3310/hta9120
M Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, 629, 10.1136/bmj.315.7109.629
CB Begg, 1994, Operating characteristics of a rank correlation test for publication bias, Biometrics, 50, 1088, 10.2307/2533446
JP Higgins, 2002, Quantifying heterogeneity in a meta-analysis, Statistics in medicine, 21, 1539, 10.1002/sim.1186
S Duval, 2000, Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis, Biometrics, 56, 455, 10.1111/j.0006-341X.2000.00455.x
A Cistaro, 2013, Prediction of 2 years-survival in patients with stage I and II non-small cell lung cancer utilizing (18)F-FDG PET/CT SUV quantification, Radiology and oncology, 47, 219, 10.2478/raon-2013-0023
G Melloni, 2013, New positron emission tomography derived parameters as predictive factors for recurrence in resected stage I non-small cell lung cancer, European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 39, 1254, 10.1016/j.ejso.2013.07.092
K Ohtaka, 2013, Outcome analysis of (18)F-fluorodeoxyglucose positron-emission tomography in patients with lung cancer after partial volume correction, Anticancer research, 33, 5193
SH Hyun, 2013, Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection, Annals of surgery, 257, 364, 10.1097/SLA.0b013e318262a6ec
K Kim, 2012, Prognostic value of volumetric parameters measured by F-18 FDG PET/CT in surgically resected non-small-cell lung cancer, Nuclear medicine communications, 33, 613, 10.1097/MNM.0b013e328351d4f5
Y Lin, 2012, Prognostic value of preoperative metabolic tumor volumes on PET-CT in predicting disease-free survival of patients with stage I non-small cell lung cancer, Anticancer research, 32, 5087
H Zhang, 2013, Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer, Academic radiology, 20, 32, 10.1016/j.acra.2012.07.002
M Agarwal, 2010, Revisiting the prognostic value of preoperative (18)F-fluoro-2-deoxyglucose ((18)F-FDG) positron emission tomography (PET) in early-stage (I & II) non-small cell lung cancers (NSCLC), European journal of nuclear medicine and molecular imaging, 37, 691, 10.1007/s00259-009-1291-x
C Dooms, 2009, Association between 18F-fluoro-2-deoxy-D-glucose uptake values and tumor vitality: prognostic value of positron emission tomography in early-stage non-small cell lung cancer, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer, 4, 822, 10.1097/JTO.0b013e3181a97df7
B Goodgame, 2008, Prognostic value of preoperative positron emission tomography in resected stage I non-small cell lung cancer, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer, 3, 130, 10.1097/JTO.0b013e318160c122
FX Hanin, 2008, Prognostic value of FDG uptake in early stage non-small cell lung cancer, European journal of cardio-thoracic surgery: official journal of the European Association for Cardio-thoracic Surgery, 33, 819, 10.1016/j.ejcts.2008.02.005
YS Kim, 2011, Prediction of survival and cancer recurrence using F-18 FDG PET/CT in patients with surgically resected early stage (Stage I and II) non-small cell lung cancer, Neoplasma, 58, 245, 10.4149/neo_2011_03_245
VS Nair, 2010, Veterans Affairs Solitary Nodule Accuracy Project Cooperative Studies G. PET scan 18F-fluorodeoxyglucose uptake and prognosis in patients with resected clinical stage IA non-small cell lung cancer, Chest, 137, 1150, 10.1378/chest.09-2356
SW Um, 2009, Prognostic value of 18F-FDG uptake on positron emission tomography in patients with pathologic stage I non-small cell lung cancer, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer, 4, 1331, 10.1097/JTO.0b013e3181b6be3e
H Vesselle, 2007, Fluorodeoxyglucose uptake of primary non-small cell lung cancer at positron emission tomography: new contrary data on prognostic role, Clinical cancer research: an official journal of the American Association for Cancer Research, 13, 3255, 10.1158/1078-0432.CCR-06-1128
ZJ Zhang, 2007, 18F-FDG uptake as a biologic factor predicting outcome in patients with resected non-small-cell lung cancer, Chinese medical journal, 120, 125, 10.1097/00029330-200701020-00010
A Bille, 2013, The prognostic significance of maximum standardized uptake value of primary tumor in surgically treated non-small-cell lung cancer patients: analysis of 413 cases, Clinical lung cancer, 14, 149, 10.1016/j.cllc.2012.04.007
K Dhital, 2000, [(18)F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer, European journal of cardio-thoracic surgery: official journal of the European Association for Cardio-thoracic Surgery, 18, 425, 10.1016/S1010-7940(00)00535-2
K Higashi, 2002, 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer, Journal of nuclear medicine: official publication, Society of Nuclear Medicine, 43, 39
HR Kim, 2009, The significance of maximum standardized uptake values in patients with stage I pulmonary adenocarcinoma, European journal of cardio-thoracic surgery: official journal of the European Association for Cardio-thoracic Surgery, 35, 712, 10.1016/j.ejcts.2008.12.030
T Ohtsuka, 2006, Prognostic significance of [(18)F]fluorodeoxyglucose uptake on positron emission tomography in patients with pathologic stage I lung adenocarcinoma, Cancer, 107, 2468, 10.1002/cncr.22268
BM Stiles, 2013, Ratio of positron emission tomography uptake to tumor size in surgically resected non-small cell lung cancer, The Annals of thoracic surgery, 95, 397, 10.1016/j.athoracsur.2012.07.038
M Tomita, 2012, Maximum SUV on positron emission tomography and serum CEA level as prognostic factors after curative resection for non-small cell lung cancer, Asia-Pacific journal of clinical oncology, 8, 244, 10.1111/j.1743-7563.2012.01549.x
Y Tsutani, 2011, Difference in prognostic significance of maximum standardized uptake value on [18F]-fluoro-2-deoxyglucose positron emission tomography between adenocarcinoma and squamous cell carcinoma of the lung, Japanese journal of clinical oncology, 41, 890, 10.1093/jjco/hyr062
A van Baardwijk, 2007, The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer, Eur J Cancer, 43, 1392, 10.1016/j.ejca.2007.03.027
RJ Downey, 2007, Fluorine-18 fluorodeoxyglucose positron emission tomographic maximal standardized uptake value predicts survival independent of clinical but not pathologic TNM staging of resected non-small cell lung cancer, The Journal of thoracic and cardiovascular surgery, 133, 1419, 10.1016/j.jtcvs.2007.01.041
HK Koo, 2011, Factors associated with recurrence in patients with curatively resected stage I-II lung cancer, Lung Cancer, 73, 222, 10.1016/j.lungcan.2010.11.013
E Pelosi, 2011, Prognostic role of the PET parameter maximum standardized uptake value in non small cell lung cancer: analysis in tumour of diameter >/ = and <25 mm, Q J Nucl Med Mol Imaging, 55, 72
S Shiono, 2011, Positron emission tomography/computed tomography and lymphovascular invasion predict recurrence in stage I lung cancers, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer, 6, 43, 10.1097/JTO.0b013e3181f9abca
DH Kim, 2014, Prediction for recurrence using F-18 FDG PET/CT in pathologic N0 lung adenocarcinoma after curative surgery, Annals of surgical oncology, 21, 589, 10.1245/s10434-013-3270-5
L Domachevsky, 2015, Survival Prognostic Value of Morphological and Metabolic variables in Patients with Stage I and II Non-Small Cell Lung Cancer, European radiology
KH Ko, 2015, Predictive value of 18F-FDG PET and CT morphologic features for recurrence in pathological stage IA non-small cell lung cancer, Medicine, 94, e434, 10.1097/MD.0000000000000434
N Motono, 2014, Differences in the prognostic significance of the SUVmax between patients with resected pulmonary Adenocarcinoma and squamous cell carcinoma. Asian Pacific journal of cancer prevention, APJCP, 15, 10171
SY Park, 2015, Prognostic value of total lesion glycolysis by 18F-FDG PET/CT in surgically resected stage IA non-small cell lung cancer, Journal of nuclear medicine: official publication, Society of Nuclear Medicine, 56, 45, 10.2967/jnumed.114.147561
K Shimizu, 2014, Difference in prognostic values of maximal standardized uptake value on fluorodeoxyglucose-positron emission tomography and cyclooxygenase-2 expression between lung adenocarcinoma and squamous cell carcinoma, World journal of surgical oncology, 12, 343, 10.1186/1477-7819-12-343
Ie R Yoo, 2014, Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis, Bio-medical materials and engineering, 24, 3091, 10.3233/BME-141131
M Vaidya, 2012, Combined PET/CT image characteristics for radiotherapy tumor response in lung cancer, Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology, 102, 239, 10.1016/j.radonc.2011.10.014
F Tixier, 2014, Visual Versus Quantitative Assessment of Intratumor 18F-FDG PET Uptake Heterogeneity: Prognostic Value in Non-Small Cell Lung Cancer, Journal of nuclear medicine: official publication, Society of Nuclear Medicine, 55, 1235, 10.2967/jnumed.113.133389
SR Kang, 2014, Intratumoral Metabolic Heterogeneity for Prediction of Disease Progression After Concurrent Chemoradiotherapy in Patients with Inoperable Stage III Non-Small-Cell Lung Cancer, Nuclear medicine and molecular imaging, 48, 16, 10.1007/s13139-013-0231-7
GJ Cook, 2013, Are pretreatment 18F-FDG PET tumor textural features in non-small cell lung cancer associated with response and survival after chemoradiotherapy?, Journal of nuclear medicine: official publication, Society of Nuclear Medicine, 54, 19, 10.2967/jnumed.112.107375
R Boellaard, 2004, Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study, Journal of nuclear medicine: official publication, Society of Nuclear Medicine, 45, 1519
A Stahl, 2004, Comparison of different SUV-based methods for monitoring cytotoxic therapy with FDG PET, European journal of nuclear medicine and molecular imaging, 31, 1471, 10.1007/s00259-004-1626-6
P Lee, 2007, Metabolic tumor burden predicts for disease progression and death in lung cancer. International journal of radiation oncology, biology, physics, 69, 328
M Machtay, 2013, Prediction of survival by [18F]fluorodeoxyglucose positron emission tomography in patients with locally advanced non-small-cell lung cancer undergoing definitive chemoradiation therapy: results of the ACRIN 6668/RTOG 0235 trial, Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 31, 3823, 10.1200/JCO.2012.47.5947